Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Thromb Haemost ; 99(2): 352-6, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18278185

RESUMO

Obesity is associated with the changes of plasminogen activator inhibitor-1 (PAI-1), tumor necrosis factor-alpha (TNFalpha) and transforming growth factor beta (TGFbeta) levels. However, the precise effect of the 4G allele on obesity is still contradictory. Here, we aimed to elucidate the role of the 4G/5G polymorphism of the PAI-1 gene on the PAI-1 level and determine the associations between cytokines, glucose and lipid metabolism parameters in obese children. Thirty-nine obese children (mean age 11.4 +/- 3.3 years) and 38 age-matched healthy control group (mean age 10.3 +/- 3.5 years) were included in the study. In all cases, serum levels of glucose, lipid and insulin were measured, homeostasis model assessment of insulin resistance (HOMA-IR) was calculated, and 4G/5G polymorphism of PAI-1 gene, plasma PAI-1 level and serum TNFalpha and TGFbeta levels were studied. The mean relative body mass index (BMI) and HOMA-IR score, VLDL, TG, insulin, PAI-1, TNFalpha levels were higher, and HDL and TGFbeta levels were lower in the obese group. The frequency of the 4G/4G genotype was considerably higher in obese children than in controls. Also, a positive correlation was found between PAI-1 and TNFalpha levels, and relative BMI, HOMA-IR score, insulin, TG, HDL levels. TGFbeta was inversely correlated only with relative BMI. There was no correlation among three cytokines. In conclusion, childhood obesity contributes to higher PAI-1 and TNFalpha and lower TGFbeta levels. Especially PAI-1 and TNFalpha accompany insulin resistance and dyslipidemia.


Assuntos
Glicemia/metabolismo , Citocinas/sangue , Metabolismo dos Lipídeos , Obesidade/genética , Inibidor 1 de Ativador de Plasminogênio/genética , Polimorfismo Genético , Tecido Adiposo/metabolismo , Adolescente , Glicemia/genética , Índice de Massa Corporal , Estudos de Casos e Controles , Criança , Citocinas/genética , Feminino , Predisposição Genética para Doença , Humanos , Insulina/sangue , Resistência à Insulina/genética , Metabolismo dos Lipídeos/genética , Lipídeos/sangue , Masculino , Obesidade/sangue , Obesidade/metabolismo , Fenótipo , Inibidor 1 de Ativador de Plasminogênio/sangue , Regiões Promotoras Genéticas , Fatores de Risco , Fator de Crescimento Transformador beta/sangue , Fator de Necrose Tumoral alfa/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA